|
시장보고서
상품코드
1642790
동물 건강 시장 보고서 : 동물 유형별, 제품 유형별, 지역별(2025-2033년)Animal Health Market Report by Animal Type (Commercial, Companion), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2025-2033 |
||||||
세계의 동물 건강 시장 규모는 2024년 390억 달러에 달했습니다. IMARC Group은 향후 2033년에는 513억 달러에 이를 전망이며, 2025년부터 2033년까지 2.79%의 성장률(CAGR)을 나타낼 것으로 예측했습니다. 이 시장을 견인하고 있는 것은 반려동물을 키우는 사람 증가와 양질의 수의학에 대한 그들의 요구, 인수 공통 감염에 대한 의식 증가, 그리고 세계의 다양한 기술의 진보입니다.
동물 건강은 가축 및 야생 동물의 행복과 적절한 기능 상태를 의미합니다. 동물의 신체적, 정신적, 행동적 측면을 포함하여 전반적인 건강과 삶의 질을 중시합니다. 동물 건강을 보장하기 위해서는 예방 의료, 적시에 예방 접종, 적절한 영양 섭취, 정기적인 수의학 등 다양한 조치를 취해야 합니다. 동물 건강을 적절하게 관리하는 것은 개별 동물의 복지와 동물과 인간 집단 모두에 영향을 줄 수 있는 질병의 확산을 예방하고 통제하는 데 필수적입니다. 그 결과 동물 건강은 지속 가능한 농업, 야생 동물의 보호, 사회에서 인간과 동물의 유대를 지원하는 중요한 역할을 수행합니다.
동물성 단백질에 대한 수요 증가와 반려동물 사육률 증가는 예측 기간 동안 시장 성장을 자극하는 것으로 보입니다. 게다가, 인수 공통 감염에 대한 의식 증가와 원헬스 접근법은 동물의 예방 의료와 질병 관리의 중요성을 강조하고 있습니다. 이에 따라 새롭게 개선된 동물 건강 솔루션의 연구개발(R&D)에 대한 광범위한 투자가 시장 성장에 긍정적인 영향을 미치고 있습니다. 이와는 별도로, 동물 건강 개입의 효능을 높이는 혁신적인 진단, 의약품, 치료 방법 등 수의학에서 수많은 기술적 진보가 고급 수의학 제품에 대한 수요를 증가시키고 있습니다. 또한, 동물 복지와 바이오 보안을 촉진하기 위해 정부의 유리한 규제와 이니셔티브가 시장 성장을 뒷받침하고 있습니다. 이에 더해 식품의 안전성과 품질에 대한 주목 증가가 보다 건강하고 안전한 식품 공급망을 확보하기 위해 가축생산에서 동물용 위생제품의 채용을 가속화하고 있습니다. 게다가 신흥국의 가처분소득 증가로 반려동물 케어에 대한 소비자 지출이 증가하고 있는 것도 시장 성장에 기여하고 있습니다.
예방 건강 관리에 대한 관심 증가
동물 의료 산업에서는 반려 동물과 가축의 예방 건강 관리로의 전환이 현저합니다. 반려 동물 주인과 가축 생산자는 동물의 전반적인 행복을 개선하고 질병의 위험을 줄이기 위해 건강 문제의 조기 발견과 사전 관리의 중요성을 인식하고 있습니다. 수의사에 의한 정기적인 건강 진단, 백신 접종, 각각에 맞는 건강 관리 플랜이 일반적으로 되고 있습니다. 이 동향은 가축의 삶의 질을 향상시키고 축산에서 질병 발생에 의한 경제적 영향을 최소화하고자 하는 욕망에 힘쓰고 있습니다. 그 결과, 백신, 기생충 구제제, 영양 보조 식품 등, 예방적인 동물용 의약품에 대한 수요가 높아지고 있습니다.
생명공학 및 의약품의 진보
동물용 의약품 분야에서는 생명공학과 의약품의 진보가 눈부시고, 동물의 질병의 진단이나 치료 방법이 크게 바뀌고 있습니다. 최첨단 연구와 혁신적인 기술은 특정 동물 종과 병태에 맞는 특수 요법, 백신 및 정밀 의료를 개발하고 있습니다. 유전자 편집 및 세포 기반 치료법과 같은 생명 공학의 획기적인 진보는 문제가 되는 질병에 대한 유망한 해결책을 제공합니다. 또한 제약회사는 동물에 의해 효과적이고 안전한 의약품을 개발하기 위한 연구개발(R&D)에 투자하고 있습니다. 이러한 진보는 치료 성적을 향상시키고 동물 건강 관리 전체의 효율화에 공헌하고 있습니다. 수의사의 전문가들은 보다 적극적인 맞춤 치료 계획을 제공할 수 있게 되어, 그 결과 치료를 받고 있는 동물들의 치료 성적이 향상되어 생활의 질이 향상되고 있습니다.
증가하는 반려 동물의 인간화 및 전문적인 반려 동물 관리
인간과 반려 동물 사이의 관계 진화는 반려 동물의 인간화로 알려진 현상으로 이어집니다. 반려 동물은 점점 더 중요한 가족 구성원으로 간주되어 반려 동물 케어 시장에서 소비자 행동에 큰 변화가 있습니다. 반려 동물의 주인은 사랑하는 반려 동물이 건강하고 충실한 생활을 보낼 수 있도록 고도의 전문적인 반려 동물 케어 제품과 서비스에 더 많은 지출을 아끼지 않도록되어 있습니다. 이 동향은 고품질 반려 동물 영양 제품, 개인화 치료 및 고급 수의학에 대한 수요를 유발합니다. 유기농 반려동물 먹이, 맞춤형 보충제, 반려동물 전문 의료 등 다양한 전문 제품을 사용할 수 있게 된 것이 동물 의약품 시장의 성장을 뒷받침하고 있습니다.
The global animal health market size reached USD 39.0 billion in 2024. Looking forward, IMARC Group expects the market to reach USD 51.3 billion by 2033, exhibiting a growth rate (CAGR) of 2.79% during 2025-2033. The market is driven by the growing number of pet owners and their desire for high-quality veterinary care, the rising awareness towards zoonotic diseases, and various technological advancements across the globe.
Animal health refers to the state of well-being and proper functioning of animals, both domestic and wild. It encompasses the physical, mental, and behavioral aspects of animals, emphasizing their overall health and quality of life. Ensuring animal health involves taking various measures, such as preventive healthcare, timely vaccinations, appropriate nutrition, and regular veterinary care. Proper management of animal health is essential for the welfare of individual animals and for preventing and controlling the spread of diseases that can impact both animal and human populations. As a result, animal health plays a crucial role in supporting sustainable agriculture, wildlife conservation, and the human-animal bond in society.
The rising demand for animal protein and the growing pet ownership rate will stimulate the growth of the market during the forecast period. Moreover, the heightening awareness of zoonotic diseases and the One Health approach have emphasized the importance of preventive care and disease management in animals. In line with this, extensive investments in research and development (R&D) of new and improved animal health solutions are positively influencing the market growth. Apart from this, numerous technological advancements in veterinary medicine, such as innovative diagnostics, pharmaceuticals, and treatment modalities that enhance the effectiveness of animal health interventions, has augmented the demand for advanced veterinary products. Additionally, favorable government regulations and initiatives aimed at promoting animal welfare and biosecurity are propelling the market growth. Besides this, the increasing focus on food safety and quality has accelerated the adoption of animal health products in livestock production to ensure healthier and safer food supply chains. Furthermore, the inflating consumer spending on pet care due to rising disposable incomes in emerging economies is contributing to the market growth.
Increasing focus on preventive healthcare
The animal health industry is experiencing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet owners and livestock producers recognize the importance of early detection and proactive management of health issues to improve overall animal well-being and reduce the risk of diseases. Regular veterinary check-ups, vaccinations, and tailored health management plans are becoming commonplace. This trend is fueled by a desire to enhance the quality of life for animals and minimize the economic impact of disease outbreaks in livestock production. As a result, there is a growing demand for preventive animal health products, including vaccines, parasiticides, and nutritional supplements.
Advancements in biotechnology and pharmaceuticals
The animal health sector is witnessing remarkable advancements in biotechnology and pharmaceuticals, transforming the way diseases are diagnosed and treated in animals. Cutting-edge research and innovative technologies have led to the development of specialized therapies, vaccines, and precision medicine tailored to specific animal species and conditions. Biotechnological breakthroughs, such as gene editing and cell-based therapies, offer promising solutions for challenging diseases. Additionally, pharmaceutical companies are investing in research and development (R&D) to create more effective and safer medications for animals. These advancements improve treatment outcomes and contribute to the overall efficiency of animal healthcare. Veterinary professionals can now offer more targeted and personalized treatment plans, leading to better outcomes and enhanced quality of life for animals under their care.
Growing pet humanization and specialty pet care
The evolving relationship between humans and their pets has led to a phenomenon known as pet humanization. Pets are increasingly regarded as integral family members, resulting in a significant shift in consumer behavior in the pet care market. Pet owners are now willing to spend more on premium and specialized pet care products and services to ensure their beloved companions lead healthy and fulfilling lives. This trend has catalyzed the demand for high-quality pet nutrition products, personalized treatments, and advanced veterinary care. The availability of a wide range of specialty products, such as organic pet food, customized supplements, and pet-specific medical treatments is propelling the growth of the market for animal health.
Commercial
Companion
Commercial holds the largest share in the market
The commercial segment typically includes animals, such as livestock and poultry, that are reared for commercial needs like milk and meat. Producers and farmers are increasingly focused on maintaining the health and productivity of their herds or flocks due to the rising demand for animal-derived products, including meat, dairy, and eggs. Healthy animals lead to higher yields and improved product quality, which directly impacts the profitability of commercial operations. To achieve optimal productivity, producers are investing in preventive healthcare measures, like vaccinations, parasite control, and disease management. This in turn, has augmented the demand for a wide range of animal health products, such as vaccines, pharmaceuticals, feed additives, and hygiene solutions. The rising collaboration between commercial animal producers and veterinary professionals ensures the implementation of best practices in animal health management, thus favoring the market growth.
Pharmaceuticals
Biologicals
Medicinal Feed Additives
Diagnostics
Pharmaceuticals represent the most popular product type
Pharmaceuticals refer to essential medications and therapies used to address a wide range of health conditions in animals. These pharmaceutical products cater to both companion animals and livestock, helping prevent and treat diseases, manage chronic conditions, and enhance overall animal well-being. Veterinary pharmaceutical companies are investing heavily in research and development (R&D) to create innovative and effective drugs tailored to specific animal species and health needs, thereby contributing to the segment growth. Moreover, continuous advancements in pharmaceutical technologies, such as controlled-release formulations and personalized medicine, further optimizes treatment outcomes. Additionally, pharmaceutical companies are collaborating with veterinarians, animal owners, and regulatory authorities to ensure product safety, efficacy, and compliance with stringent quality standards. Furthermore, the increasing demand for animal healthcare and the growing importance of preventive medicines are propelling the market growth.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.
North America held the biggest share in the market since the region has a large population of pet owners who prioritize the health and well-being of their companion animals, which has augmented demand for veterinary products and services. Moreover, the expanding livestock industry in North America fuels the need for animal health solutions to ensure the health and productivity of the commercial animal sector. Additionally, the presence of leading pharmaceutical companies and research institutions in the region that fosters continuous innovation in animal health products, including vaccines, pharmaceuticals, and diagnostics has catalyzed the market growth. Another major contributing aspect is the introduction of supportive government regulations and initiatives promoting animal welfare and biosecurity, encouraging investments in the animal health industry, thereby propelling the market growth.
The market is experiencing steady growth as key players are introducing several cutting-edge innovations to address evolving challenges and enhance animal care. They are developing advanced vaccines and therapeutics targeting specific diseases prevalent in both companion animals and livestock. Additionally, novel diagnostic tools employing advanced technologies, such as DNA testing and point-of-care devices, have been introduced by manufacturers to enable faster and more accurate disease detection. Key players are also investing in telemedicine and digital health solutions, facilitating remote consultations and personalized treatment plans for pet owners. Furthermore, the integration of data analytics and artificial intelligence (AI) technologies has improved decision-making in animal health management, optimizing treatment protocols and predictive modeling. These latest innovations by leading players in the market reflect their commitment to delivering state-of-the-art solutions and driving the animal health industry toward a more efficient and compassionate approach to animal care. We also expect the market to witness new entrants, consolidation of portfolios, and increased collaborations to drive healthy competition within the domain during the forecast period (2025-2033).
Bayer
Elanco
Merck
Merial
Zoetis Inc.
Biogenesis Bago
Boehringer Ingelheim
Ceva Sante Animale
Heska
Neogen
Novartis
Thermo Fisher Scientific
Vetoquinol
Virbac